109 related articles for article (PubMed ID: 2646720)
21. Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias.
Grossman ME; Poh-Fitzpatrick MB
Dermatol Clin; 1986 Apr; 4(2):297-309. PubMed ID: 3955900
[TBL] [Abstract][Full Text] [Related]
22. Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
Muñoz JJ; Garcia-Cabezas J; Martinez-Verano J; Perez-Oteyza C; Enriquez de Salamanca R
J Dermatol; 1990 May; 17(5):329-31. PubMed ID: 2380437
[TBL] [Abstract][Full Text] [Related]
23. Coexistent variegate porphyria and porphyria cutanea tarda.
Day RS; Eales L; Meissner D
N Engl J Med; 1982 Jul; 307(1):36-41. PubMed ID: 7078623
[No Abstract] [Full Text] [Related]
24. Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal.
Tishler PV; Winston SH
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):645-8. PubMed ID: 2084460
[TBL] [Abstract][Full Text] [Related]
25. [Recent clinicopathological findings on porphyrin-heme metabolism].
Wada O; Manabe S
Rinsho Byori; 1981 Jun; (46 Suppl):66-79. PubMed ID: 7334656
[No Abstract] [Full Text] [Related]
26. [Porphyrin excretion and blood iron under pyridoxal-5-phosphate administration in porphria cutanea tarda].
Petres J; Schröder K; Consbruch U; Ladner HA
Dtsch Med Wochenschr; 1967 Aug; 92(34):1498-502. PubMed ID: 6047898
[No Abstract] [Full Text] [Related]
27. Hepatic metabolism of bromosulphthalein in porphyria cutanea tarda.
Enríquez de Salamanca R; Ladero JM; Catalan T; Mas V; Rico R; Olmos A
Int J Biochem; 1980; 12(5-6):855-9. PubMed ID: 7450141
[No Abstract] [Full Text] [Related]
28. Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion.
Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Ventura E
Liver; 1984 Aug; 4(4):280-4. PubMed ID: 6482687
[TBL] [Abstract][Full Text] [Related]
29. [Therapy of porphyria cutanea tarda through metabolic alkalization with uralyt-U].
Schmidt H; Misgeld V
Hautarzt; 1972 Jun; 23(6):259-62. PubMed ID: 5054369
[No Abstract] [Full Text] [Related]
30. [Porphyria variegata--the first case in Norway].
Sandberg S; Brun A; Larsen S; Nyfors A; Nyfors B
Tidsskr Nor Laegeforen; 1990 Mar; 110(9):1082-4. PubMed ID: 2330564
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis].
Ferioli A; De Vincentiis A; Buizza P; Pasolini G; Leali C; De Panfilis G; Alessio L
Minerva Med; 1992 May; 83(5):269-75. PubMed ID: 1589131
[TBL] [Abstract][Full Text] [Related]
32. Insulin resistance in porphyria cutanea tarda.
Calcinaro F; Basta G; Lisi P; Cruciani C; Pietropaolo M; Santeusanio F; Falorni A; Calafiore R
J Endocrinol Invest; 1989 Jun; 12(6):393-9. PubMed ID: 2671111
[TBL] [Abstract][Full Text] [Related]
33. Healing by second intention in porphyria cutanea tarda.
Frumkin A; Matlock MS
J Dermatol Surg Oncol; 1987 Nov; 13(11):1158, 1161. PubMed ID: 3668058
[No Abstract] [Full Text] [Related]
34. Treatment of porphyria cutanea tarda.
Malina L
Br J Dermatol; 1987 Jan; 116(1):139-40. PubMed ID: 3814510
[No Abstract] [Full Text] [Related]
35. [Effect of chloroquine in porphyria cutanea tarda].
Herrero C; Muniesa A
Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
[TBL] [Abstract][Full Text] [Related]
36. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
Bidrat MS
Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
[No Abstract] [Full Text] [Related]
37. Porphyria variegata: failure of chloroquin treatment.
Cramers M; Jepsen LV
Acta Derm Venereol; 1980; 60(1):89-91. PubMed ID: 6153849
[TBL] [Abstract][Full Text] [Related]
38. The first Swedish case of congenital erythropoietic porphyria, with a revised view of the porphyrin excretion pattern in this disease.
Stenberg B; With TK
Acta Derm Venereol Suppl (Stockh); 1982; 100():87-90. PubMed ID: 6962640
[TBL] [Abstract][Full Text] [Related]
39. [Clinical studies of the treatment of porphyria cutanea tarda with antitoxic fraction of the liver and cyanocobalamin].
Valenzano L
Minerva Med; 1967 Oct; 58(85):3633-5. PubMed ID: 6061469
[No Abstract] [Full Text] [Related]
40. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
Doss MO
Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
